1. Home
  2. MOV vs AVXL Comparison

MOV vs AVXL Comparison

Compare MOV & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Movado Group Inc.

MOV

Movado Group Inc.

HOLD

Current Price

$21.70

Market Cap

416.4M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.14

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOV
AVXL
Founded
1961
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.4M
397.6M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
MOV
AVXL
Price
$21.70
$4.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$31.50
$22.00
AVG Volume (30 Days)
162.2K
4.1M
Earning Date
11-25-2025
11-25-2025
Dividend Yield
6.52%
N/A
EPS Growth
27.72
N/A
EPS
0.97
N/A
Revenue
$661,205,000.00
N/A
Revenue This Year
$2.10
N/A
Revenue Next Year
$0.24
N/A
P/E Ratio
$22.13
N/A
Revenue Growth
2.78
N/A
52 Week Low
$12.85
$2.86
52 Week High
$21.82
$14.44

Technical Indicators

Market Signals
Indicator
MOV
AVXL
Relative Strength Index (RSI) 65.97 38.83
Support Level $20.39 $3.66
Resistance Level $21.38 $4.88
Average True Range (ATR) 0.66 0.42
MACD 0.06 0.19
Stochastic Oscillator 91.23 55.29

Price Performance

Historical Comparison
MOV
AVXL

About MOV Movado Group Inc.

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: